Alzheimer’s treatment roadblocks can be eased by engaging primary care providers in screenings

There is substantial geographic variation across the U.S. health care system to diagnose and treat early-stage Alzheimer’s disease with disease-modifying therapies, and engaging primary care providers in the effort may be a key to accelerating delivery of emerging new treatments, according to a new RAND report.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup